اثربخشی مداخلۀ گروهی مبتنی بر رویکرد امید درمانی بر سلامت عمومی و امیدواریِ زنان مبتلا به بیماری مولتیپل اسکروزیس شهر کرمانشاه در سال 1400

نوع مقاله : مقاله پژوهشی

نویسندگان

1 کارشناس ارشد، گروه روانشناسی، دانشگاه آزاد اسلامی، واحد کرمانشاه، کرمانشاه، ایران.

2 دانشیار، مرکز تحقیقات علوم دارویی، انستیتو سلامت، دانشگاه علوم پزشکی کرمانشاه، کرمانشاه، ایران.

3 استادیار، گروه روانشناسی، دانشگاه آزاد اسلامی، واحد کرمانشاه، کرمانشاه، ایران.

10.22123/chj.2023.337662.1890

چکیده

مقدمه: مولتیپل اسکلروزیس یکی از شایع‏ ترین بیماری‏های مزمن سیستم عصبی مرکزی است. مزمن بودن بیماری، پیش ‎آگهی نامعلوم، درمان غیرقطعی و درگیر ساختن فرد در سنین جوانی، تبعات متعدد روانی-اجتماعی ایجاد می‏کند. این پژوهش با هدف تعیین اثربخشی مداخله گروهی مبتنی بر رویکرد امید درمانی بر سلامت عمومی و امیدواری مبتلایان به ام‏اس انجام شد.
مواد و روش ‏ها: این پژوهش نیمه­ آزمایشی با طرح پیش ‏آزمون-پس‏ آزمون و گروه گواه بود. جمعیت پژوهش شامل تمامی زنان مبتلا به بیماری ام‏اس تحت پوشش انجمن ام‏اس شهر کرمانشاه بود که از میان آن‏ها به شیوه در دسترس، 30 نفر انتخاب و با انتساب تصادفی در دو گروه مساوی 15 نفری گمارش شدند. اطلاعات با چک‌لیست اطلاعات دموگرافیک، پرسشنامه سلامت عمومی Goldberg و پرسشنامه امیدواری  Herth گردآوری شد. برنامه مبتنی بر امید درمانی طی 8 جلسه هفتگی به مدت 5/1 ساعت برای گروه آزمایش اجرا شد اما گروه گواه این برنامه را دریافت نکردند. داده ‏ها با روش تحلیل کواریانس چندمتغیری تحلیل شد.
یافته‏ ها: تحلیل داده ‏ها نشان داد که بین میانگین نمرات پس‏ آزمون گروه آزمایش و گواه تفاوت معنی‏ داری وجود دارد (05/0>p)، به ‌نحوی‌که برنامه امید درمانی موجب ارتقای امید (40/8=F، 012/0>p، 619/0=Eta) و سلامت عمومی در گروه آزمایش شد (42/23=F، 008/0>p، 631/0=Eta). میانگین نمره شاخص ‏های اضطراب، افسردگی، عملکرد اجتماعی و علائم جسمانی در آزمودنی‏ های گروه آزمایش در پس‏آزمون بهبود نشان داد (05/0>p). 
نتیجه ‏گیری: به نظر می‏ رسد امید درمانی گروهی در بهبود میزان امیدواری و ارتقای سلامت عمومی بیماران ام‏اس از اثربخشی مطلوبی برخوردار باشد. لذا استفاده از مداخلات روان‏شناختی در محیط‏ های درمانی پیشنهاد می‏گردد.

کلیدواژه‌ها


عنوان مقاله [English]

The Effectiveness of the Hope Therapy Approach on Group Happiness in General Health and Hope of Women Patients with Multiple Sclerosis in Kermanshah in 2021

نویسندگان [English]

  • F Abasabadi 1
  • Z Sadeghi 1
  • MH Farzaei 2
  • M Heydarian 3
1 MSc, Dept of Psychology, Kermanshah Branch, Islamic Azad University, Kermanshah, Iran. (Corresponding Author)
2 Associate Prof, Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
3 Assistant Prof, Dept of Psychology, Kermanshah Branch, Islamic Azad University, Kermanshah, Iran.
چکیده [English]

Introduction: Multiple sclerosis is one of the most common chronic diseases affecting the central nervous system. The chronic nature of the disease, the unknown prognosis, the uncertain treatment, and the involvement of the individual at a young age lead tonumerous psychosocial consequences for these patients. Therefore, this study was conducted to determine the effectiveness of group intervention based on the hope therapy approach in general health and hope of patients with MS.
Materials and Methods: This was a quasi-experimental study with a pre-test-post-test design and a control group. The study population included all women with MS under the auspices of the Kermanshah MS Association, among which 30 people were selected by convenience sampling and randomly assigned to two equal groups of 15 people. Data were collected using a checklist of demographic information, General Health Questionnaire (Goldberg & Hillier, 1979), and Hope Questionnaire (Herth, 1989). The hope-based therapy program was administered to the experimental group for 1/5 hours in 8 weekly sessions, but the control group did not receive this program. Data were analyzed by multivariate analysis of covariance.
Results: Data analysis showed that there was a significant difference between the mean post-test scores of the experimental and control groups (p<0.05) so that the hope therapy program promotes hope (F= 8.40, p<0.012, Eta= 0.619) and general health in the experimental group (F= 23.42, p<0.008, Eta= 0.631). Moreover, the mean scores of anxiety, depression, social functioning, and physical symptoms in the experimental group showed improvement in the post-test.
Conclusion: It seems that, as a treatment of choice, group hope therapy is effective in improving the level of hope and promoting the general health of MS patients. Therefore, the use of psychological interventions in therapeutic settings is recommended.

کلیدواژه‌ها [English]

  • Hope therapy
  • General health
  • Hope
  • MS
  1. Lanz TV, Brewer RC, Ho PP, Moon JS, Jude KM, Fernandez D, et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 2022; 603(79):321-27.
  2. Rovira À, Traboulsee A, Reich DS, Wattjes MP. The reality of multiple sclerosis assessment in middle-income countries–Authors' reply. Lancet Neurology 2022; 21(3):215-16.
  3. Baghbanian SM, Hosseinnataj A, Eskandarieh S, Sahraian M. A Report of multiple sclerosis registry in mazandaran province 2019-2021. JMUMS 2022: 32(207):95-101. [Persian]
  4. Newland P, Basan Y, Chen L, Wu G. Depression and inflammatory markers in veterans with multiple sclerosis. BRN 2022: 24(1):123-27.
  5. Schorr EM, Kurz D, Rossi KC, Zhang M, Yeshokumar AK, Jette N, et al. Depression readmission risk is elevated in multiple sclerosis compared to other chronic illnesses. Multiple Sclerosis 2022; 28(1):139-48.
  6. Bijoux Leist J, Leist TP. Multiple sclerosis: relationship between locus of control and quality of life in persons with low versus high disability. HPBM 2022: 10(1):316-34.
  7. Louapre C, Ibrahim M, Maillart E, Abdi B, Papeix C, Stankoff B, et al. Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders. JNNP 2022; 93(1):24-31.
  8. Cree BA, Oksenberg JR, Hauser SL. Multiple sclerosis: two decades of progress. Lancet Neurology 2022: 21(3):211-14.
  9. White V, Linardon J, Stone JE, Holmes-Truscott E, Olive L, Mikocka-Walus A, et al. Online psychological interventions to reduce symptoms of depression, anxiety, and general distress in those with chronic health conditions: A systematic review and meta-analysis of randomized controlled trials. Psychological Medicine 2022: 52(3):548-73.
  10. Schorr EM, Kurz D, Rossi KC, Zhang M, Yeshokumar AK, Jette N, et al. Depression readmission risk is elevated in multiple sclerosis compared to other chronic illnesses. Multiple Sclerosis 2022; 28(1):139-48.
  11. Lucas L, Parker J. Physiotherapists perceived role in managing anxiety in patients with relapsing-remitting multiple sclerosis: a mixed-methods study. Archives of Physiotherapy 2022: 12(1):1-13.
  12. Smyrke N, Dunn N, Murley C, Mason D. Standardized mortality ratios in multiple sclerosis: Systematic review with meta‐analysis. Acta Neurologica Scandinavica 2022: 145(3):360-70.
  13. Joseph S, Sagy S. Positive Psychology and Its Relation to Salutogenesis. In The Handbook of Salutogenesis. Springer, Cham 2022: 233-38.
  14. Downey CA, Chang EC, Zettler I, Yang H, Muyan-Yilikm M. The International Handbook of Positive Psychology. Springer, Cham 2022:557-66.
  15. Goldzweig G, Baider L, Jacobs JM, Ghrayeb IM, Sapir E, Rottenberg Y. Depression, hope and social support among older people with cancer: a comparison of muslim palestinian and jewish Israeli cancer patients. SCC 2022: 30(2):1511-19.
  16. Neate SL, Donald A, Jelinek GA, Nag N. Experiences of and attitudes to lifestyle modification for the management of multiple sclerosis: A qualitative analysis of free‐text survey data. Health Expectations 2022: 25(1):214-22.
  17. Macfarlane J. Positive psychology pioneers: Professor Martin Seligman's power and potential to influence mental health nursing. BJMHN 2022; 11(1):1-8.
  18. Torbay R. Why Project HOPE Is Growing Our US Programming: Project HOPE president and CEO Rabih Torbay describes the organization’s growing domestic programming. Health Affairs 2022; 41(3):468-68.
  19. Lorenzo‐Blanco EI, Zhang M, Cobb C, Meca A, Szapocznik J, Unger JB, et al. Longitudinal change in adolescent hope among recent immigrant Latinx adolescents: Links with adolescent and parent cultural stress, family functioning, emotional well‐being, and behavioral health. Child Development 2022; 93(1):87-102.
  20. Hadoush H, Alawneh A, Kassab M, Al-Wardat M, Al-Jarrah M. Effectiveness of non-pharmacological rehabilitation interventions in pain management in patients with multiple sclerosis: Systematic review and meta-analysis. NeuroRehabilitation 2022;50(4):347-365.
  21. Hashemizadeh Nehi N, Jajarmi M, Mahdian H. The Effectiveness of group hope therapy on academic procrastination and self-regulation among female high school student learning in Mashhad. JEPS 2020; 17(39):102-77. [Persian]
  22. Khalili Doabi M, Goodarzi K, Roozbahani M, Karimi J. Comparison of the effectiveness of hope therapy and cognitive-behavioral psychotherapy on depression in adolescent female students. Islamic Life Style 2021; 5 (2):118-25. [Persian]
  23. Khaloei G, Aleyasin S, Heidari H, Davoudi H. Comparison of The effectiveness of educational intervention based on hope therapy approach and mindfulness-based cognitive therapy approach on perceived social support of women with multiple sclerosis. medical journal of mashhad university of medical sciences 202; 64(2):2807-25. [Persian]
  24. Khalili Dooabi M, Goodarzi K, Karimi J, Roozbahani M. Comparison the effectiveness of hope therapy and cognitive behavioral psychotherapy on anger and anxiety of adolescents. Journal of Social Psychology 2021; 8(58):177-88. [Persian]
  25. Snyder CR. Handbook of hope: Theory, measures, and applications. 4nd New York: Publisher Elsevier Science, 2000.
  26. Javadian SN, Emami T. The comparison of the effect of the number of aerobic and yoga sessions on physical self-description components of female university students. Development and Motor Learning 2009; 18(2):127-45. [Persian]
  27. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychological Medicine 1979; 9(1):139-45.
  28. Taghavi SMR. Validity of General Health Questionnaire. Journal of Psychology 2002; 5(4):381-98. [Persian]
  29. Herth K. Abbreviated instrument to measure hope: Development and psychometric evaluation. JAN 1992; 17(10):1251–59.
  30. Abdi N, Lari MA. Standardization of Three hope scales, as possible measures at the end of life, in iranian population. IJCM 2011; 4(2):71-7. [Persian]
  31. Duncan AR, Jaini PA, Hellman CM. Positive psychology and hope as lifestyle medicine modalities in the therapeutic encounter: a narrative review. AJLM 2021; 15(1):6-13.
  32. Makaremnia S, Dehghan Manshadi M, Khademian Z. Effects of a positive thinking program on hope and sleep quality in Iranian patients with thalassemia: a randomized clinical trial. BMC psychology 2021; 9(1):2-10. [Persian]
  33. Kiani J, Hajiuni A, Gholizadeh F, Abbasi F. Efficacy of cognitive-behavioral therapy and hope therapy on quality of life, life expectancy and resiliency in patients with thalassemia. Journal of Shahid Sadoughi University of Medical Sciences 2019; 27(4):1482-95. [Persian]